Structural Basis of Anthocyanin-Mediated Modulation of IL-2, IL-17, and TNF-α: A Docking and Molecular Dynamics Study
Abstract
1. Introduction
2. Results
2.1. Molecular Docking Results of Anthocyanins with Cytokines (TNF, IL-2, and IL-17)
2.2. Amino Acid Interaction Analysis Using LigPlot+
2.3. ADMET Analysis of Primulin and Antirrhinin
2.4. Molecular Dynamics Simulation
2.5. Gene Expression
3. Discussion
4. Materials and Methods
4.1. Materials
4.1.1. Molecular Docking
4.1.2. Interaction Analysis
4.1.3. ADMET Analysis
4.1.4. Molecular Dynamics
4.1.5. In Vivo Experiments
4.1.6. Gene Expression Analysis
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Zheng, X.; Zhang, X.; Zeng, F. Biological functions and health benefits of flavonoids in fruits and vegetables: A contemporary review. Foods 2025, 14, 155. [Google Scholar] [CrossRef]
- Pietta, P.G. Flavonoids as antioxidants. J. Nat. Prod. 2000, 63, 1035–1042. [Google Scholar] [CrossRef]
- Hwang, J.-W.; Kim, E.-K.; Lee, S.-J.; Kim, Y.-S.; Moon, S.-H.; Jeon, B.-T.; Sung, S.-H.; Kim, E.-T.; Park, P.-J. Antioxidant activity and protective effect of anthocyanin oligomers on H2O2-triggered G2/M arrest in retinal cells. J. Agric. Food Chem. 2012, 60, 4282–4288. [Google Scholar] [CrossRef]
- Sadowska-Bartosz, I.; Bartosz, G. Antioxidant activity of anthocyanins and anthocyanidins: A critical review. Int. J. Mol. Sci. 2024, 25, 12001. [Google Scholar] [CrossRef] [PubMed]
- Gilani, S.J.; Bin-Jumah, M.N.; Al-Abbasi, F.A.; Nadeem, M.S.; Imam, S.S.; Alshehri, S.; Ghoneim, M.M.; Afzal, M.; Alzarea, S.I.; Sayyed, N.; et al. Rosinidin flavonoid ameliorates hyperglycemia, lipid pathways and proinflammatory cytokines in streptozotocin-induced diabetic rats. Pharmaceutics 2022, 14, 547. [Google Scholar] [CrossRef] [PubMed]
- Rathee, P.; Chaudhary, H.; Rathee, S.; Rathee, D.; Kumar, V.; Kohli, K. Mechanism of action of flavonoids as anti-inflammatory agents: A review. Inflamm. Allergy-Drug Targets 2009, 8, 229–235. [Google Scholar] [CrossRef]
- Testai, L.; Martelli, A.; Cristofaro, M.; Breschi, M.C.; Calderone, V. Cardioprotective effects of different flavonoids against myocardial ischaemia/reperfusion injury in Langendorff-perfused rat hearts. J. Pharm. Pharmacol. 2013, 65, 750–756. [Google Scholar] [CrossRef] [PubMed]
- Bjune, K.; Halvorsen, P.S.; Wangensteen, H.; Leren, T.P.; Bogsrud, M.P.; Strøm, T.B. Flavonoids regulate LDLR through different mechanisms tied to their specific structures. J. Lipid Res. 2024, 65, 100539. [Google Scholar] [CrossRef]
- Vinayagam, R.; Xu, B. Antidiabetic properties of dietary flavonoids: A cellular mechanism review. Nutr. Metab. 2015, 12, 60. [Google Scholar] [CrossRef]
- García-Lafuente, A.; Guillamón, E.; Villares, A.; Rostagno, M.A.; Martínez, J.A. Flavonoids as anti-inflammatory agents: Implications in cancer and cardiovascular disease. Inflamm. Res. 2009, 58, 537–552. [Google Scholar] [CrossRef]
- Yudina, R.S.; Gordeeva, E.I.; Shoeva, O.Y.; Tikhonova, M.A.; Khlestkina, E.K. Anthocyanins as components of functional nutrition. Vavilov J. Genet. Breed. 2021, 25, 178–189. [Google Scholar] [CrossRef] [PubMed]
- Les, F.; Cásedas, G.; Gómez, C.; Moliner, C.; Valero, M.S.; López, V. The role of anthocyanins as antidiabetic agents: From molecular mechanisms to in vivo and human studies. J. Physiol. Biochem. 2021, 77, 109–131. [Google Scholar] [CrossRef]
- Mao, T.; Akshit, F.N.U.; Mohan, M.S. Effects of anthocyanin supplementation in diet on glycemic and related cardiovascular biomarkers in patients with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials. Front. Nutr. 2023, 10, 1199815. [Google Scholar] [CrossRef]
- Strathearn, K.E.; Yousef, G.G.; Grace, M.H.; Roy, S.L.; Tambe, M.A.; Ferruzzi, M.G.; Wu, Q.-L.; Simon, J.E.; Lila, M.A.; Rochet, J.-C. Neuroprotective effects of anthocyanin- and proanthocyanidin-rich extracts in cellular models of Parkinson’s disease. Brain Res. 2014, 1555, 60–77. [Google Scholar] [CrossRef] [PubMed]
- Beydoun, M.A.; Beydoun, H.A.; Wang, Y. Long-term dietary flavonoid intake and risk of Alzheimer disease and related dementias among US adults. Am. J. Clin. Nutr. 2022, 115, 1013–1023. [Google Scholar] [CrossRef]
- Monteiro, A.F.; Scotti, L.; Viana, J.d.O.; Nayarisseri, A.; Zondegoumba, E.N.; Junior, F.J.B.M.; Scotti, M.T. Computational studies applied to flavonoids against Alzheimer’s and Parkinson’s diseases. Oxidative Med. Cell. Longev. 2018, 2018, 7912765. [Google Scholar] [CrossRef]
- Alshehri, S.; Imam, S.S. Rosinidin attenuates lipopolysaccharide-induced memory impairment in rats: Possible mechanisms of action include antioxidant and anti-inflammatory effects. Biomolecules 2021, 11, 1747. [Google Scholar] [CrossRef]
- Sravani, M.; Kumaran, A.; Dhamdhere, A.T.; Kumar, N.S. Computational molecular docking analysis and visualisation of anthocyanins for anticancer activity. Int. J. Res. Appl. Sci. Biotechnol. 2021, 8, 154–161. [Google Scholar] [CrossRef]
- Karcheva-Bahchevanska, D.; Nikolova, M.; Iliev, I. Inhibitory potential of different bilberry (Vaccinium myrtillus L.) extracts on human salivary α-amylase. Molecules 2023, 28, 5820. [Google Scholar] [CrossRef] [PubMed]
- Huang, W.-Y.; Liu, Y.-M.; Wang, J.; Wang, X.-N.; Li, C.Y. Anti-inflammatory effect of the blueberry anthocyanins malvidin-3-glucoside and malvidin-3-galactoside in endothelial cells. Molecules 2014, 19, 12827. [Google Scholar] [CrossRef]
- Thilavech, T.; Adisakwattana, S. Cyanidin-3-rutinoside acts as a natural inhibitor of intestinal lipid digestion and absorption. BMC Complement. Med. Ther. 2019, 19, 242. [Google Scholar] [CrossRef]
- Calderaro, A.; Barreca, D.; Bellocco, E.; Smeriglio, A.; Trombetta, D.; Laganà, G. Colored phytonutrients: Role and applications in the functional foods of anthocyanins. In Phytonutrients in Food: From Traditional to Rational Usage; Nabavi, S.M., Suntar, I., Barreca, D., Khan, H., Eds.; Woodhead Publ.: Hamilton, UK, 2020; pp. 177–195. [Google Scholar] [CrossRef]
- Livak, K.J.; Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods 2001, 25, 402–408. [Google Scholar] [CrossRef]
- Li, D.; Wang, P.; Luo, Y.; Zhao, M.; Chen, F. Health benefits of anthocyanins and molecular mechanisms: Update from recent decade. Crit. Rev. Food Sci. Nutr. 2017, 57, 1729–1741. [Google Scholar] [CrossRef] [PubMed]
- Promyos, N.; Temviriyanukul, P.; Suttisansanee, U. Investigation of Anthocyanidins and Anthocyanins for Targeting α-Glucosidase in Diabetes Mellitus. Prev. Nutr. Food Sci. 2020, 25, 263–271. [Google Scholar] [CrossRef]
- Young, A.; Ajaz, M.; Vugic, L.; Shilton, N. Anthocyanin Supplementation and Inflammation: A Systematic Review and Meta-Analysis of IL-8, IL-10, IL-18, IFN-γ, and Resistin in Healthy, Overweight, and Obese Populations. Food Sci. Nutr. 2026, 14, e71527. [Google Scholar] [CrossRef] [PubMed]
- Kozłowska, A.; Dzierżanowski, T. Targeting Inflammation by Anthocyanins as the Novel Therapeutic Potential for Chronic Diseases: An Update. Molecules 2021, 26, 4380. [Google Scholar] [CrossRef]
- Welch, C.R.; Wu, Q.; Simon, J.E. Recent advances in anthocyanin analysis and characterization. Curr. Anal. Chem. 2008, 4, 75–101. [Google Scholar] [CrossRef] [PubMed]
- Kim, S.; Chen, J.; Cheng, T.; Gindulyte, A.; He, J.; He, S.; Li, Q.; Shoemaker, B.A.; Thiessen, P.A.; Yu, B.; et al. PubChem 2025 update. Nucleic Acids Res. 2025, 53, D1516–D1525. [Google Scholar] [CrossRef]
- Williams, A.J. Public chemical compound databases. Curr. Opin. Drug Discov. Dev. 2008, 11, 393–404. [Google Scholar]
- AutoDock Vina. (n.d.). Available online: http://vina.scripps.edu (accessed on 15 August 2025).
- MGLTools—Molecular Graphics Laboratory. (n.d.). Available online: http://mgltools.scripps.edu/downloads (accessed on 15 August 2025).
- UniProt Consortium. UniProt: The universal protein knowledgebase in 2021. Nucleic Acids Res. 2021, 49, D480–D489. [Google Scholar] [CrossRef]
- Tang, S.; Chen, R.; Lin, M.; Lin, Q.; Zhu, Y.; Ding, J.; Hu, H.; Ling, M.; Wu, J. Accelerating AutoDock Vina with GPUs. Molecules 2022, 27, 3041. [Google Scholar] [CrossRef]
- Schrödinger, L.; DeLano, W. PyMOL. 2020. Available online: http://www.pymol.org/pymol (accessed on 15 August 2025).
- O’Boyle, N.M.; Banck, M.; James, C.A.; Morley, C.; Vandermeersch, T.; Hutchison, G.R. Open Babel: An open chemical toolbox. J. Cheminform. 2011, 3, 33. [Google Scholar] [CrossRef]
- Agrawal, R.; Punarva, H.B.; Heda, G.O.; Vishesh, Y.M.; Karunakar, P. VinaLigGen: A method to generate LigPlots and retrieval of hydrogen and hydrophobic interactions from protein–ligand complexes. J. Biomol. Struct. Dyn. 2023, 42, 7255–7264. [Google Scholar] [CrossRef]
- Fu, L.; Shi, S.; Yi, J.; Wang, N.; He, Y.; Wu, Z.; Peng, J.; Deng, Y.; Wang, W.; Wu, C.; et al. ADMETlab 3.0: An updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support. Nucleic Acids Res. 2024, 52, W94–W103. [Google Scholar] [CrossRef] [PubMed]
- Law of the Republic of Kazakhstan No. 214-II of July 9, 2001. On State Support of Scientific and (or) Scientific and Technical Activities. Available online: https://adilet.zan.kz/rus/docs/V2000021512 (accessed on 15 August 2025).
- Jiang, X.; Li, X.; Zhu, C.; Sun, J.; Tian, L.; Chen, W.; Bai, W. The target cells of anthocyanins in metabolic syndrome. Crit. Rev. Food Sci. Nutr. 2018, 58, 2540–2553. [Google Scholar] [CrossRef] [PubMed]
- Zhang, X.; Zhu, Y.; Song, F.; Yao, Y.; Ya, F.; Li, D.; Ling, W.; Yang, Y. Effects of purified anthocyanin supplementation on platelet chemokines in hypocholesterolemic individuals: A randomized controlled trial. Nutr. Metab. 2016, 13, 86. [Google Scholar] [CrossRef]
- Vendrame, S.; Klimis-Zacas, D. Anti-inflammatory effect of anthocyanins via modulation of nuclear factor-κB and mitogen-activated protein kinase signaling cascades. Nutr. Rev. 2015, 73, 348–358. [Google Scholar] [CrossRef]
- Sangsefidi, Z.S.; Hasanizadeh, S.; Hosseinzadeh, M. Effect of purified anthocyanins or anthocyanin-rich extracts on C-reactive protein levels: A systematic review and meta-analysis of randomised clinical trials. Br. J. Nutr. 2018, 120, 1406–1414. [Google Scholar] [CrossRef] [PubMed]
- Cenk, E.; Schmutz, C.; Pahlke, G.; Oertel, A.; Kollarova, J.; Mock, H.-P.; Matros, A.; Marko, D. Immunomodulatory properties of blackberry anthocyanins in THP-1 derived macrophages. Int. J. Mol. Sci. 2021, 22, 10483. [Google Scholar] [CrossRef]










| # | Compounds | Binding Energy (kcal/mol) | |||||
|---|---|---|---|---|---|---|---|
| TNF-α | IL-2 | IL-17 | |||||
| Max | Min | Max | Min | Max | Min | ||
| 1. A | Cyanidin | −5.6 | −5.1 | −6.2 | −5.5 | −7.5 | −6.6 |
| 2. B | Delphinidin | −5.6 | −5.0 | −6.1 | −5.6 | −7.4 | −6.1 |
| 3. C | Aurantinidin | −5.6 | −4.9 | −6.8 | −5.9 | −7.6 | −6.3 |
| 4. D | Chrysanthemin | −5.9 | −5.5 | −6.7 | −6.2 | −8.9 | −7.5 |
| 5. E | Peonidin | −5.9 | −5.0 | −6.2 | −5.6 | −7.3 | −6.8 |
| 6. F | Petunidin | −6.1 | −5.3 | −6.2 | −5.9 | −7.6 | −6.7 |
| 7. G | Malvidin | −5.4 | −5.0 | −6.0 | −5.7 | −7.4 | −6.8 |
| 8. H | Pelargonidin | −5.5 | −4.8 | −7.2 | −5.8 | −7.5 | −6.5 |
| 9. I | Myrtillin | −6.9 | −6.5 | −7.5 | −7.1 | −9.8 | −8.9 |
| 10. J | Primulin | −7.3 | −6.4 | −8.1 | −7.1 | −9.2 | −8.6 |
| 11. K | Oenin | −5.7 | −5.4 | −6.0 | −5.8 | −8.5 | −7.3 |
| 12. L | Antirrhinin | −9.6 | −8.4 | −9.5 | −8.6 | −11.6 | −10.0 |
| 2D visualization of the interaction of primulin with TNF-α | H-bonds | Hydrophobic interactions |
![]() | Asn113(A), Tyr229(A) | Ser225(A), Tyr138(A), His94(A), Val96(A), Gly226(A) |
| 2D visualization of the interaction of antirrhinin with TNF-α | H-bonds | Hydrophobic interactions |
![]() | Tyr197(A) | His94(A), Leu115(A), Asn113(A), Tyr138(A), Leu136(A), Gly226(A), Tyr229(A), Gln140(A) |
| 2D visualization of the interaction of primulin with IL-2 | H-bonds | Hydrophobic interactions |
![]() | Arg145(A) | Pro71(A), Trp146(A), Ala74(A), Phe149(A), Gln73(A), Thr75(A), Leu70(A), Lys72(A) |
| 2D visualization of the interaction of antirrhinin with IL-2 | H-bonds | Hydrophobic interactions |
![]() | Trp146(A), Pro71(A), Phe149(A), Ser152(A), Ala74(A), Lys72(A) | |
| 2D visualization of the interaction of primulin with IL-17 | H-bonds | Hydrophobic interactions |
![]() | Ala83(A) | Leu80(A), Glu33(A), Lys82(A), His38(A), Ser31(A), Pro42(A), Arg101(A), Leu45(A), Lys85(A), Thr84(A), Trp34(A) |
| 2D visualization of the interaction of antirrhinin with IL-17 | H-bonds | Hydrophobic interactions |
![]() | Ser31(A), Leu45(A), Tyr97(A) | Trp34(A), Glu33(A), Asp44(A), Lys85(A), Cys87(A) |
| Property | Model Name | Unit | Primulin | Antirrhinin |
|---|---|---|---|---|
| Absorption | Caco-2 Permeability | Numeric (log Papp in 10−6 cm/s) | −6.221 | −6.593 |
| MDCK Permeability | Numeric (log Papp in 10−6 cm/s) | −5.328 | −5.02 | |
| Pgp-inhibitor | Probability (0–1) | 0.0 | 0.0 | |
| Pgp-substrate | Probability (0–1) | 0.831 | 0.827 | |
| HIA | Probability (0–1) | 0.818 | 0.746 | |
| F20% | Probability (0–1) | 0.478 | 0.984 | |
| F30% | Probability (0–1) | 0.981 | 1.0 | |
| Distribution | PPB | % | 77.773 | 83.4 |
| BBB permeability | Numeric (log BB) | 0.0 | 0.001 | |
| Metabolism | CYP1A2 inhibitor | Probability (0–1) | 0.0 | 0.0 |
| CYP1A2 substrate | Probability (0–1) | 0.0 | 0.0 | |
| CYP2C19 inhibitor | Probability (0–1) | 0.0 | 0.0 | |
| CYP2C19 substrate | Probability (0–1) | 0.002 | 0.0 | |
| CYP2C9 inhibitor | Probability (0–1) | 0.0 | 0.0 | |
| CYP2C9 substrate | Probability (0–1) | 0.999 | 0.009 | |
| CYP2D6 inhibitor | Probability (0–1) | 0.0 | 0.0 | |
| CYP2D6 substrate | Probability (0–1) | 0.995 | 0.0 | |
| CYP3A4 inhibitor | Probability (0–1) | 0.0 | 0.0 | |
| CYP3A4 substrate | Probability (0–1) | 0.009 | 0.0 | |
| Excretion | CL | Numeric (mL/min/kg) | 2.483 | 1.495 |
| T1/2 | Numeric (h) | 3.121 | 5.143 | |
| Toxicity | hERG Blockers | Probability (0–1) | 0.011 | 0.003 |
| H-HT | Probability (0–1) | 0.001 | 0.002 | |
| Tox21 pathway | NR-PPAR-gamma | Probability (0–1) | 0.0 | 0.001 |
| SR-ARE | Probability (0–1) | 0.341 | 0.204 | |
| SR-p53 | Probability (0–1) | 0.107 | 0.146 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Bogoyavlenskiy, A.; Manakbayeva, A.; Kerimov, T.; Yershov, I.; Alexyuk, M.; Alexyuk, P.; Berezin, V.; Dushenkov, V. Structural Basis of Anthocyanin-Mediated Modulation of IL-2, IL-17, and TNF-α: A Docking and Molecular Dynamics Study. Int. J. Mol. Sci. 2026, 27, 3479. https://doi.org/10.3390/ijms27083479
Bogoyavlenskiy A, Manakbayeva A, Kerimov T, Yershov I, Alexyuk M, Alexyuk P, Berezin V, Dushenkov V. Structural Basis of Anthocyanin-Mediated Modulation of IL-2, IL-17, and TNF-α: A Docking and Molecular Dynamics Study. International Journal of Molecular Sciences. 2026; 27(8):3479. https://doi.org/10.3390/ijms27083479
Chicago/Turabian StyleBogoyavlenskiy, Andrey, Adolat Manakbayeva, Timur Kerimov, Igor Yershov, Madina Alexyuk, Pavel Alexyuk, Vladimir Berezin, and Vyacheslav Dushenkov. 2026. "Structural Basis of Anthocyanin-Mediated Modulation of IL-2, IL-17, and TNF-α: A Docking and Molecular Dynamics Study" International Journal of Molecular Sciences 27, no. 8: 3479. https://doi.org/10.3390/ijms27083479
APA StyleBogoyavlenskiy, A., Manakbayeva, A., Kerimov, T., Yershov, I., Alexyuk, M., Alexyuk, P., Berezin, V., & Dushenkov, V. (2026). Structural Basis of Anthocyanin-Mediated Modulation of IL-2, IL-17, and TNF-α: A Docking and Molecular Dynamics Study. International Journal of Molecular Sciences, 27(8), 3479. https://doi.org/10.3390/ijms27083479







